Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://www.science.org/doi/10.1126/science.342.6165.1432, but it redirected us to https://www.science.org/doi/10.1126/science.342.6165.1432. The analysis below is for the second page.

Title[redir]:
Cancer Immunotherapy | Science
Description:
This year marks a turning point in cancer, as long-sought efforts to unleash the immune system against tumors are paying off—even if the future remains a question mark.

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌍 Impressive Traffic: 500k - 1M visitors per month


Based on our best estimate, this website will receive around 600,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We don’t know how the website earns money.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Doi.org might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

cancer, science, news, crossref, immunotherapy, cells, immune, article, antibody, years, patients, melanoma, therapy, issue, tumor, aaas, access, information, treatment, share, view, ctla, antipd, citation, jul, commentary, journals, authors, options, system, researchers, tumors, drug, june, eletters, advertisement, full, figures, cell, target, year, metastatic, disease, allison, university, published, antibodies, antictla, advanced, reported,

Topics {✒️}

reviewers librarians manage �immunology beats cancer authors information altounian/science crucial results home science vol articles partner jennifer couzin-frankel bristol-myers squibb reported social media facebook science news journals member current issue science family account bristol-myers squibb web sites award-winning scienceadviser newsletter celebrating cancer immunotherapy—harnessing permissions toc alerts contents advertisement sign skip slideshow news science family advances made science' science showing science volume 342 science faq science donate science issn 0036-8075 scholarly commentary citation information award-winning newsletter �t-cell therapy side effects milder biological responses induced latest news latest news full text article genetic microsurgery single issue reprints aaas member activate faqs access cancer immunotherapy passes major drug companies transform biological insights pharmaceutical companies shied baltimore coffee shop involves genetically modifying odds remain long gut microbiota modulation

Questions {❓}

  • In celebrating cancer immunotherapy—harnessing the immune system to battle tumors—did we risk hyping an approach whose ultimate impact remains unknown?

External Links {🔗}(155)

Analytics and Tracking {📊}

  • Facebook Pixel
  • Google Analytics
  • Google Tag Manager
  • OneSignal
  • Quantcast
  • Site Verification - Facebook

Libraries {📚}

  • Animate.css
  • Dropzone.js
  • Moment.js
  • Normalize.css
  • Slick
  • Swiper
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Cloudflare
  • Onesignal

2.63s.